This year’s talk series focuses on drug policy as it has been informed (or not informed, as the case may be!) by neuroscience. Is the “brain to blame” for addicts’ behavior? Is vaping a kinder, gentler substitute for smoking, or a new scourge? Should we take a fresh look at the therapeutic and personal growth potential of psychedelic drugs? Join us for discussions of these issues and more!
